Commonwealth Bank of Australia’s Regeneron Pharmaceuticals REGN Stock Holding History

Commonwealth Bank of Australia’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,033	Closed	-$945K	–	741
2019 Q2	$945K	Sell	3,033 -44	-1%	-$14.6K	0.01%	574
2019 Q1	$1.26M	Buy	3,077 +1,000	+48%	+$412K	0.01%	506
2018 Q4	$770K	Buy	2,077 +1,406	+210%	+$515K	0.01%	545
2018 Q3	$268K	Buy	671 +600	+845%	+$228K	﹤0.01%	860
2018 Q2	$23K	Buy	71 +30	+73%	+$9.38K	﹤0.01%	729
2018 Q1	$12K	Hold	41	–	–	﹤0.01%	746
2017 Q4	$14K	Sell	41 -1	-2%	-$405	﹤0.01%	739
2017 Q3	$17K	Sell	42 -302	-88%	-$144K	﹤0.01%	724
2017 Q2	$167K	Sell	344 -13	-4%	-$5.69K	﹤0.01%	647
2017 Q1	$138K	Buy	357 +8	+2%	+$2.96K	﹤0.01%	639
2016 Q4	$128K	Buy	349 +81	+30%	+$30.8K	﹤0.01%	609
2016 Q3	$108K	Hold	268	–	–	﹤0.01%	622
2016 Q2	$93K	Sell	268 -2	-0.7%	-$770	﹤0.01%	626
2016 Q1	$97K	Buy	270 +28	+12%	+$11.5K	﹤0.01%	634
2015 Q4	$132K	Buy	242 +28	+13%	+$15.2K	﹤0.01%	643
2015 Q3	$100K	Buy	214 +3	+1%	+$1.61K	﹤0.01%	656
2015 Q2	$108K	Buy	211 +11	+6%	+$5.37K	﹤0.01%	608
2015 Q1	$90K	Hold	200	–	–	﹤0.01%	603
2014 Q4	$82K	Sell	200 -1,600	-89%	-$629K	﹤0.01%	597
2014 Q3	$649K	Hold	1,800	–	–	0.01%	557
2014 Q2	$508K	Sell	1,800 -8,683	-83%	-$2.57M	0.01%	579
2014 Q1	$3.15M	Buy	10,483 +1,531	+17%	+$472K	0.02%	553
2013 Q4	$2.46M	Buy	8,952 +592	+7%	+$170K	0.02%	585
2013 Q3	$2.62M	Buy	8,360 +730	+10%	+$192K	0.02%	535
2013 Q2	$1.72M	Buy	+7,630	New	+$1.78M	0.01%	605

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Commonwealth Bank of Australia's REGN Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Regeneron Pharmaceuticals (REGN) in Q3 2019, closing a stake of 3,033 shares — an estimated $945K sold.

Commonwealth Bank of Australia first reported a position in REGN in Q2 2013 and held it in 25 quarters. The position peaked at $3.15M in Q1 2014. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Regeneron Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 3,033 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $945K.
Commonwealth Bank of Australia first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 25 quarters.
Commonwealth Bank of Australia's Regeneron Pharmaceuticals position peaked at $3.15M in Q1 2014.
633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.